Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

Engineered bivalent ligands to bias ErbB receptor-mediated signaling and phenotypes.

Jay SM, Kurtagic E, Alvarez LM, de Picciotto S, Sanchez E, Hawkins JF, Prince RN, Guerrero Y, Treasure CL, Lee RT, Griffith LG.

J Biol Chem. 2011 Aug 5;286(31):27729-40. doi: 10.1074/jbc.M111.221093. Epub 2011 May 26.

2.

The neuregulin-I/ErbB signaling system in development and disease.

Britsch S.

Adv Anat Embryol Cell Biol. 2007;190:1-65. Review.

PMID:
17432114
3.

The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

Citri A, Skaria KB, Yarden Y.

Exp Cell Res. 2003 Mar 10;284(1):54-65. Review.

PMID:
12648465
4.

The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands.

Tzahar E, Yarden Y.

Biochim Biophys Acta. 1998 Feb 20;1377(1):M25-37. Review.

PMID:
9540810
5.

Biology of HER2 and its importance in breast cancer.

Yarden Y.

Oncology. 2001;61 Suppl 2:1-13. Review.

PMID:
11694782
6.

The EGF receptor family--multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4.

Earp HS 3rd, Calvo BF, Sartor CI.

Trans Am Clin Climatol Assoc. 2003;114:315-33; discussion 333-4. Review.

7.

The roles of neuregulin-1 in cardiac development, homeostasis, and disease.

Rupert CE, Coulombe KL.

Biomark Insights. 2015 Apr 8;10(Suppl 1):1-9. doi: 10.4137/BMI.S20061. eCollection 2015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk